- Home
- USEG vs ESLA Comparison
USEG vs ESLA Comparison
Compare USEG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- ESLA
- Stock Information
- Founded
- USEG 1966
- ESLA 2021
- Country
- USEG United States
- ESLA United States
- Employees
- USEG N/A
- ESLA N/A
- Industry
- USEG Oil & Gas Production
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USEG Energy
- ESLA Health Care
- Exchange
- USEG Nasdaq
- ESLA Nasdaq
- Market Cap
- USEG 45.0M
- ESLA 41.6M
- IPO Year
- USEG N/A
- ESLA N/A
- Fundamental
- Price
- USEG $2.32
- ESLA $1.18
- Analyst Decision
- USEG Strong Buy
- ESLA
- Analyst Count
- USEG 2
- ESLA 0
- Target Price
- USEG $2.00
- ESLA N/A
- AVG Volume (30 Days)
- USEG 154.4K
- ESLA 17.0K
- Earning Date
- USEG 11-12-2024
- ESLA 02-12-2025
- Dividend Yield
- USEG N/A
- ESLA N/A
- EPS Growth
- USEG N/A
- ESLA N/A
- EPS
- USEG N/A
- ESLA N/A
- Revenue
- USEG $22,257,000.00
- ESLA N/A
- Revenue This Year
- USEG N/A
- ESLA N/A
- Revenue Next Year
- USEG $12.17
- ESLA N/A
- P/E Ratio
- USEG N/A
- ESLA N/A
- Revenue Growth
- USEG N/A
- ESLA N/A
- 52 Week Low
- USEG $0.81
- ESLA $0.63
- 52 Week High
- USEG $2.43
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- USEG 73.28
- ESLA 51.64
- Support Level
- USEG $1.41
- ESLA $1.05
- Resistance Level
- USEG $2.43
- ESLA $1.27
- Average True Range (ATR)
- USEG 0.18
- ESLA 0.15
- MACD
- USEG 0.06
- ESLA -0.01
- Stochastic Oscillator
- USEG 87.64
- ESLA 53.33
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business activities in South Texas and the Williston Basin in North Dakota. The company generates revenue from its interest in the sales of oil and natural gas production.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.